Theranostics · 2020 · 63 citations · 43 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer Molecular PathologyCancer ProgressionColorectal CancerEpithelial-mesenchymal TransitionSignal Transduction In CancerCancer Signaling PathwaysColorectal Cancer PrognosisEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersQuantitative Polymerase Chain ReactionReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction AssaysWestern Blotting
Our results suggest that the CSRP2/p130Cas/Rac1 axis can inhibit CRC aggressiveness and metastasis through the Hippo, ERK, and PAK signaling pathways. Therefore, CSRP2 may be a potential therapeutic target for CRC.
43
Sarah Heerboth, Genevieve Housman, Meghan Leary et al. · Clinical and Translational Medicine · 2015 · 760 citations · Full text
Medicine, Cancer Biology, Oncology +17
Heather A. Louis, Josephine D. Pino, Karen Schmeichel et al. · Journal of Biological Chemistry · 1997 · 209 citations · Full text
Haiou Yang, Haiyang Zhang, Yuchong Yang et al. · Theranostics · 2020 · 209 citations · Full text
Medicine, Cancer Biology, Oncology +17